About the Leukemia Program

The Leukemia and Bone Marrow Failure Program at NewYork Presbyterian Hospital/Weill Cornell Medical Center is a comprehensive program with internationally recognized leaders for patients with acute and chronic leukemias, myelodysplastic syndrome, myeloproliferative disorders and bone marrow failure.

The Leukemia Program provides:

• A multidisciplinary team with specialists in infectious diseases, geriatrics, gastroenterology, cardiology, nephrology, neurology, pulmonary and critical care medicine, psychiatry, social work, nutrition and others

• Emphasis on highly personalized, individual care

• Close collaboration with comprehensive bone marrow and stem cell transplantation program

• Access to cutting edge clinical trials involving newly developed drugs, biological therapies and antibodies

• Specialized in-patient and out-patient units with highly trained staff and ancillary professionals experienced with the specific needs of these patients

• Extensive collaborations with world-renowned translational scientists, specific expertise in leukemia stem cells, genomics, epigenetics

• Specialized focus on development of clinical trials targeting leukemia stem cells, both at the time of diagnosis  as well as  trying to target and eradicate left-over leukemia stem cells in patients already in remission.

The Leukemia Fighters Fund accepts charitable donations which are completely and specifically for leukemia research at Weill Cornell, has already provided funds for new recruits, novel treatment protocols, equipment and other critical needs.